Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: results of the NEOMUN trial - Eichhorn, Martin E.; Niedermaier, Benedikt Walter; Charoentong, Pornpimol; Klotz, Laura Valentina; Baum, Philip; Griffo, Raffaella; Allgäuer, Michael; Stenzinger, Albrecht; Bischoff, Helge; Schneider, Marc; Christopoulos, Petros; Haberkorn, Uwe; et al. (Journal for ImmunoTherapy of Cancer, 2025)
Gesehen am 12.12.2025